Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 432 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

432 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 432 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

432 programs

Clinical programs

Page 9 of 9

  1. convention therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 2 small molecule completed

    1 trial

  2. conventional therapy plus low dose hUC-MSCs treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhosis

    phase 2 mab completed

    1 trial

  3. corticosteroids

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Severe Colitis (ASC)

    phase 2 small molecule active

    1 trial

  4. corticosteroids combined with immunoglobulin and romiplostim

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  5. dapagliflozin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Kidney Injury

    phase 2 small molecule active

    1 trial

  6. deferoxamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracerebral Hemorrhage

    phase 2 small molecule active

    1 trial

  7. donepezil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cognitive Impairment

    phase 2 small molecule active

    1 trial

  8. electroacupuncture group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Urinary Stress Incontinence

    phase 2 other completed

    1 trial

  9. escitalopram

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Addiction

    phase 2 small molecule terminated

    1 trial

  10. gemcitabine and cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  11. infloran

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Enterocolitis, Necrotizing

    phase 2 other terminated

    1 trial

  12. iv ibuprofen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extremely Premature Infants

    phase 2 small molecule active

    1 trial

  13. leucovorin+5-FU

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colonic Diseases

    phase 2 small molecule active

    1 trial

  14. levamisole

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anemia

    phase 2 small molecule active

    1 trial

  15. low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab completed

    1 trial

  16. mesenchymal stem cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplant

    phase 2 mab active

    1 trial

  17. mesenchymal stem cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 2 mab active

    1 trial

  18. middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Norovirus Infections

    phase 2 mab active

    1 trial

  19. nab-paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 small molecule active

    1 trial

  20. nal-IRI /Experimental

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  21. nanoliposomal irinotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head & Neck Cancer

    phase 2 small molecule completed

    1 trial

  22. nasogastric tube decompression

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreaticoduodenectomy

    phase 2 other active

    1 trial

  23. nedaplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Central Nervous System Tumors

    phase 2 small molecule active

    1 trial

  24. nerve growth factor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traumatic Brain Injury

    phase 2 small molecule completed

    1 trial

  25. nicotinamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cutaneous Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  26. nicotinamide adenine dinucleotid/nicotinamide mononucleotide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  27. nivolumab, ipilimumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule completed

    1 trial

  28. open discectomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lumbar Disc Herniation

    phase 2 other active

    1 trial

  29. oxaliplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasms

    phase 2 small molecule active

    1 trial

  30. pectin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  31. pemetrexed

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Metastases

    phase 2 small molecule active

    1 trial

  32. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypoxic-Ischemic Encephalopathy

    phase 2 small molecule completed

    1 trial

  33. recombinant human erythropoietin (rhEpo)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infant, Premature

    phase 2 small molecule active

    1 trial

  34. rhGM-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Alveolar Proteinosis

    phase 2 small molecule active

    1 trial

  35. sarcosine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  36. self-expandable 125I radioactive seeds-loaded-stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cholangiocellular Carcinoma

    phase 2 other completed

    1 trial

  37. sintilimab+IBI310+chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC Stage II

    phase 2 small molecule active

    1 trial

  38. sintiliman plus LDRT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  39. split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Influenza

    phase 2 mab completed

    2 trials

  40. standard triple region

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Helicobacter Pylori Infection

    phase 2 small molecule completed

    1 trial

  41. the standard "3+7" regimen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Newly Diagnosed Acute Myeloid Leukemia (AML)

    phase 2 small molecule active

    1 trial

  42. tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric

    phase 2 small molecule active

    1 trial

  43. tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stage III

    phase 2 small molecule active

    1 trial

  44. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cartilage Damage

    phase 2 mab active

    1 trial

  45. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral Arterial Disease

    phase 2 mab completed

    1 trial

  46. vitamin C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule completed

    1 trial

  47. zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid Syndrome

    phase 2 small molecule active

    1 trial

  48. zoledronic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Congenital Dyserythropoietic Anemia (CDA)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

432 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.